Value-based care is the predominant model for enabling the healthcare industry to control costs and deliver better information to consumers. The basic idea is that reimbursements are based on the quality of the outcome of a procedure, episode of care, use of a device or therapy. Under this model, life sciences companies are rewarded for improving health outcomes and/or reducing the costs to achieve those outcomes. It requires life sciences companies to rethink many of their processes, from R&D through the commercial phase. Navigating those momentous shifts requires that life sciences companies embrace a range of digital technologies which will enable a holistic approach to value-based care. This white paper will examine the drive for value-based care, its impact on life sciences companies and how technology platforms can address the challenges the industry is facing.